Skip to main content

Table 2 Respiratory variables during the first 24 hrs of treatment (mean ± SE)

From: A randomised controlled trial of an open lung strategy with staircase recruitment, titrated PEEP and targeted low airway pressures in patients with acute respiratory distress syndrome

 

1 hour

3 hours

6 hours

24 hours

 

PHARLAP

Control

PHARLAP

Control

PHARLAP

Control

PHARLAP

Control

VT, mls

519 ± 56

501 ± 30

517 ± 51

529 ± 58

529 ± 56

542 ± 49

463 ± 42

563 ± 65

RR, bpm

21 ± 2

21 ± 1

20 ± 2

21 ± 2

21 ± 2

21 ± 2

22 ± 2

20 ± 2

FIO2

0.47 ± 0.03

0.59 ± 0.04

0.5 ± 0.04

0.5 ± 0.03

0.4 ± 0.05

0.57 ± 0.05

0.4 ± 0.04

0.5 ± 0.04

PEEP, cm H2O

17.4 ± 1

11.6 ± 1

17.4 ± 1*

11 ± 0.5

16.7 ± 1*

10 ± 0.6

15 ± 1*

10 ± 0.5

Pplateau, cm H2O

28.9 ± 1.2

27.1 ± 1.2

28.3 ± 1.1

26.6 ± 1.1

29 ± 0.8

26 ± 0.8

27.6 ± 1.5

26.9 ± 1.4

Arterial pH

7.34 ± 0.02

7.36 ± 0.02

7.34 ± 0.02

7.34 ± 0.03

7.34 ± 0.02

7.36 ± 0.01

7.36 ± 0.01

7.35 ± 0.01

PaCO2, mm Hg

49 ± 5

46 ± 5

47 ± 4

48 ± 6

48 ± 3

45 ± 3

45 ± 3

46 ± 3

  1. *P < 0.05 for differences between PHARLAP and control groups.
  2. VT, tidal volume; RR, respiratory rate; FIO2, fraction of inspired oxygen; PEEP, positive end expiratory pressure; Pplateau, plateau pressure; PaO2/FIO2, partial pressure of oxygen to inspired fraction of oxygen ratio; PaCO2, partial pressure of carbon dioxide